2023 Q1 Form 10-Q Financial Statement

#000121390023039779 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.398M $453.4K
YoY Change 208.27% 45240.0%
% of Gross Profit
Research & Development $604.9K
YoY Change
% of Gross Profit
Depreciation & Amortization $1.085K
YoY Change
% of Gross Profit
Operating Expenses $1.398M $453.4K
YoY Change 208.27% 45240.0%
Operating Profit -$1.398M -$453.4K
YoY Change 208.27%
Interest Expense $3.124M $27.61K
YoY Change 11214.34%
% of Operating Profit
Other Income/Expense, Net $100.0K
YoY Change
Pretax Income $1.726M -$425.8K
YoY Change -505.41% 42479.0%
Income Tax $424.7K
% Of Pretax Income 24.61%
Net Earnings $1.301M -$425.8K
YoY Change -405.66% 43660.43%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.05 -$11.85K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.122M $1.627M
YoY Change -31.01%
Cash & Equivalents $1.122M $1.627M
Short-Term Investments
Other Short-Term Assets $277.9K $361.5K
YoY Change -23.12%
Inventory
Prepaid Expenses $277.9K
Receivables
Other Receivables
Total Short-Term Assets $1.400M $1.989M
YoY Change -29.58%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $297.5M $290.4M
YoY Change 2.45%
Other Assets $209.4K
YoY Change
Total Long-Term Assets $297.5M $290.6M
YoY Change 2.38%
TOTAL ASSETS
Total Short-Term Assets $1.400M $1.989M
Total Long-Term Assets $297.5M $290.6M
Total Assets $298.9M $292.6M
YoY Change 2.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $379.1K $106.8K
YoY Change 254.89%
Accrued Expenses $1.724M $796.6K
YoY Change 116.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.453M $903.4K
YoY Change 282.19%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.453M $903.4K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $13.52M $10.97M
YoY Change 23.25%
SHAREHOLDERS EQUITY
Retained Earnings -$10.54M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.54M -$8.739M
YoY Change
Total Liabilities & Shareholders Equity $298.9M $292.6M
YoY Change 2.16%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $1.301M -$425.8K
YoY Change -405.66% 43660.43%
Depreciation, Depletion And Amortization $1.085K
YoY Change
Cash From Operating Activities -$165.5K -$1.218M
YoY Change -86.4%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $255.9K
YoY Change
NET CHANGE
Cash From Operating Activities -$165.5K -1.218M
Cash From Investing Activities
Cash From Financing Activities $255.9K
Net Change In Cash -$165.5K -1.218M
YoY Change -86.4%
FREE CASH FLOW
Cash From Operating Activities -$165.5K -$1.218M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41151
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2962208
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
321 North Clark Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2440
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60654
CY2023Q1 dei City Area Code
CityAreaCode
(312)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
262-5642
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1122452 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1287986 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
277904 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
284405 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1400356 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1572391 usd
CY2023Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
297519738 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
294395846 usd
CY2023Q1 us-gaap Assets
Assets
298920094 usd
CY2022Q4 us-gaap Assets
Assets
295968237 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
379091 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
267297 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1724366 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
660491 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1227106 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
802367 usd
CY2023Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
122289 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
72289 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3452852 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1802444 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
10062500 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
10062500 usd
CY2023Q1 us-gaap Liabilities
Liabilities
13515352 usd
CY2022Q4 us-gaap Liabilities
Liabilities
11864944 usd
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
295942581 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
293293429 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q1 xpdb Common Stock Value1
CommonStockValue1
719 usd
CY2022Q4 xpdb Common Stock Value1
CommonStockValue1
719 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10538558 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9190855 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-10537839 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9190136 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
298920094 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
295968237 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1287704 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
343396 usd
CY2023Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
60000 usd
CY2022Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
60000 usd
CY2023Q1 us-gaap Franchisor Costs
FranchisorCosts
50000 usd
CY2022Q1 us-gaap Franchisor Costs
FranchisorCosts
50000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1397704 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-453396 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3123892 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
27607 usd
CY2023Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
1726188 usd
CY2022Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-425789 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
424739 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1301449 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-425789 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9190136 usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-2649152 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1301449 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-10537839 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8313691 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-425789 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-8739480 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
1301449 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-425789 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
3123892 usd
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
27607 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-6501 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-43098 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
111794 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1041267 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1063875 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
184032 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
424739 usd
CY2023Q1 xpdb Franchise Tax Payable
FranchiseTaxPayable
50000 usd
CY2022Q1 xpdb Franchise Tax Payable
FranchiseTaxPayable
50000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-165534 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1217533 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-165534 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1217533 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1287986 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2844602 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1122452 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1627069 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
2649152 usd
CY2021Q4 xpdb Offering Cost
OfferingCost
20700000 usd
CY2021Q4 xpdb Deferred Underwriting Commissions
DeferredUnderwritingCommissions
10100000 usd
CY2023Q1 xpdb Percentage Of Trust Account Required For Business Combination
PercentageOfTrustAccountRequiredForBusinessCombination
0.80 pure
CY2023Q1 xpdb Public Price Per Share
PublicPricePerShare
10.1
CY2023Q1 xpdb Net Tangible Assets
NetTangibleAssets
5000001 usd
CY2023Q1 xpdb Percentage Of Public Shares
PercentageOfPublicShares
0.15 pure
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
2900000 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5000001 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
100000 usd
CY2023Q1 xpdb Residual Assets Remaining Description
ResidualAssetsRemainingDescription
In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.10, or $10.20 or $10.30 per Public Share, as applicable, if the Company extends the period of time the Company will have to complete an initial Business Combination. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.10 per Public Share, or $10.20 or $10.30 per public share, as applicable, if the Company extends the period of time it will have to complete an initial Business Combination, or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the Trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
CY2023Q1 us-gaap Cash
Cash
1100000 usd
CY2023Q1 xpdb Working Capital
WorkingCapital
700000 usd
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1300000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.01 pure
CY2022Q3 xpdb Fair Market Value Percentage
FairMarketValuePercentage
0.01 pure
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Use of Estimates</p><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Concentration of Credit Risk</p><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times, may exceed the Federal Depository Insurance Corporation coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.246 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 xpdb Initial Public Offering Shares
InitialPublicOfferingShares
28750000 shares
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
20700000 usd
CY2021Q4 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
10100000 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q1 us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
Each Unit consists of one share of Class A common stock, and one-half of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).
CY2021Q3 xpdb Founder Shares
FounderShares
120000 shares
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
516000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
516000 usd
CY2023Q1 xpdb Percentage Of Founder Shares
PercentageOfFounderShares
0.75 pure
CY2023Q1 xpdb Private Placement Warrant Description
PrivatePlacementWarrantDescription
Each Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share.
CY2021Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
115000 usd
CY2023Q1 xpdb Working Capital Loans
WorkingCapitalLoans
1500000 usd
CY2023Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
1
CY2023Q1 us-gaap Legal Fees
LegalFees
60000 usd
CY2022Q1 us-gaap Legal Fees
LegalFees
60000 usd
CY2023Q1 xpdb Aggregate Amount
AggregateAmount
5300000 usd
CY2023Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.35
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
287500000 usd
CY2022 xpdb Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
-14662500 usd
CY2022 xpdb Issuance Costs Allocated To Class A Common Stock
IssuanceCostsAllocatedToClassACommonStock
-19627833 usd
CY2022 xpdb Adjust Carrying Value To Initial Redemption Value
AdjustCarryingValueToInitialRedemptionValue
40083762 usd
CY2023Q1 xpdb Class A Common Stock Subject To Possible Redemptions
ClassACommonStockSubjectToPossibleRedemptions
293293429 usd
CY2023Q1 xpdb Remeasurement Of Carrying Value To Initial Redemption Value
RemeasurementOfCarryingValueToInitialRedemptionValue
2649152 usd
CY2023Q1 xpdb Class A Common Stock Subject To Possibles Redemption
ClassACommonStockSubjectToPossiblesRedemption
295942581 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
28750000 shares
CY2023Q1 xpdb Percentage Of Number Of Shares
PercentageOfNumberOfShares
0.20 pure
CY2023Q1 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
CY2023Q1 xpdb Initial Business Combination Description
InitialBusinessCombinationDescription
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” to be equal to 180% of the higher of the Market Value and the Newly Issued Price described below under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
CY2023Q1 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
18
CY2023Q1 xpdb Warrants Description
WarrantsDescription
Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):  ●in whole and not in part;  ●at a price of $0.01 per warrant;  ●upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and  ●if, and only if, the last reported sale price of Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted). 
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Power & Digital Infrastructure Acquisition II Corp.
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
CY2022Q1 us-gaap Stock Issued1
StockIssued1
usd
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001855474

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
xpdb-20230331_cal.xml Edgar Link unprocessable
xpdb-20230331_lab.xml Edgar Link unprocessable
0001213900-23-039779-index-headers.html Edgar Link pending
0001213900-23-039779-index.html Edgar Link pending
0001213900-23-039779.txt Edgar Link pending
0001213900-23-039779-xbrl.zip Edgar Link pending
f10q0323ex31-1_poweranddi2.htm Edgar Link pending
f10q0323ex31-2_poweranddi2.htm Edgar Link pending
f10q0323ex32-1_poweranddi2.htm Edgar Link pending
f10q0323ex32-2_poweranddi2.htm Edgar Link pending
f10q0323_poweranddigi2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xpdb-20230331.xsd Edgar Link pending
xpdb-20230331_def.xml Edgar Link unprocessable
f10q0323_poweranddigi2_htm.xml Edgar Link completed
xpdb-20230331_pre.xml Edgar Link unprocessable